Eli Lilly And CompanyUsage: Cyramza (ramucirumab) treats advanced gastric, gastro-esophageal junction, non-small cell lung, colorectal, and hepatocellular cancers in adults, used alone or with chemotherapy after prior treatment failure or as first-line therapy for EGFR-mutant NSCLC.